Vistin Pharma
Mindre end 1K følgere
VISTN
Oslo Børs
Biotechnology & Pharmaceuticals
Health Care
Overview
Investor consensus
Vistin Pharma is a Norwegian pharmaceutical company. The company conducts research and development as well as further production of pharmaceutical substances (API), mainly the substances metformin, codeine phosphate, and Pholcodine. The substances are mainly used in the treatment of diabetes. The company operates worldwide, with the largest presence in the Nordic market. Vistin Pharma was founded in 2015 and is headquartered in Oslo, Norway.
Læs mereMarkedsværdi
-
Aktieomsætning
-
Omsætning
429,5 mio.
EBIT %
19,86 %
P/E
-
Udbytteafkast, %
-
Finanskalender
22.5
2025
Generalforsamling '25
4.6
2025
Halvårligt udbytte
15.8
2025
Delårsrapport Q2'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Vistin Pharma ASA: First quarter 2025 financial results
Vistin Pharma ASA: Invitation to Q1 2025 conference call
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools